Physician profile
Aung Naing Lin
NPI 1912389768
$3,375.30
in general payments reported to CMS, 2019-2025
13 companies · $1,114 in 2025
The $1,114 reported for 2025 was more than what 86% of Adolescent Medicine (Internal Medicine) providers received nationally (typical 2025 total: $165).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.69 · 2022: $416 · 2023: $953 · 2024: $858 · 2025: $1,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,999 · Education: $599 · Travel and Lodging: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,998.71 |
| Education | $598.98 |
| Travel and Lodging | $326.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $1,144.39 | 2022-2025 | Carto 3, Nuvision Ice Catheter, Octaray Mapping Catheter |
| Abbott Laboratories | $897.99 | 2023-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Ensite |
| Medical Device Business Services, INC. | $326.74 | 2023 | Carto 3 |
| Biotronik INC. | $287.01 | 2024-2025 | Biomonitor |
| Boston Scientific Corporation | $175.26 | 2025 | Farapulse |
| Medtronic, INC. | $164.70 | 2024 | Cobalt Dr Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $135.31 | 2023-2024 | Lifevest |
| Abbvie INC. | $78.53 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $64.99 | 2023 | Andexxa |
| Janssen Pharmaceuticals, INC | $43.78 | 2024 | Xarelto |
| Merck Sharp & Dohme LLC | $21.91 | 2025 | Verquvo |
| Siemens Medical Solutions USA, INC. | $19.39 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aung Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.